SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-21-000233
Filing Date
2021-11-23
Accepted
2021-11-23 17:07:42
Documents
17
Period of Report
2021-11-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20211119.htm   iXBRL 8-K 58689
2 EX-99.1 a8-kx23nov2021xexhibit991.htm EX-99.1 15239
3 EX-99.2 a8-kx23nov2021xexhibit992.htm EX-99.2 44007
4 EX-99.3 a8-kx23nov2021xexhibit993.htm EX-99.3 12631
5 EX-99.4 a8-kx23nov2021xexhibit994.htm EX-99.4 14042
9 image_0.jpg GRAPHIC 69
  Complete submission text file 0001651308-21-000233.txt   316550

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20211119.xsd EX-101.SCH 1996
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20211119_lab.xml EX-101.LAB 25214
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20211119_pre.xml EX-101.PRE 13249
10 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20211119_htm.xml XML 11485
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 211439525
SIC: 2834 Pharmaceutical Preparations